(Q40187770)

18 September 2017

title

Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents (English)

1 reference

18 September 2017

main subject

phase III clinical trial

0 references

1 reference

Leslie Swartz

3

0 references

Ashraf Kagee

series ordinal

2

object named as

Ashraf Kagee

1 reference

18 September 2017

Georgina Giocos

1

1 reference

18 September 2017

publication date

1 August 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

12

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

842-851

1 reference

https://scigraph.springernature.com/pub.10.1007/s10461-007-9289-5

18 September 2017

exact match

0 references

cites work

Who will enroll? Predicting participation in a phase II AIDS vaccine trial

1 reference

https://api.crossref.org/works/10.1007%2FS10461-007-9289-5

Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-007-9289-5

Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-007-9289-5

Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-007-9289-5

Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-007-9289-5

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-007-9289-5

Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-007-9289-5

10.1007/S10461-007-9289-5

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference